Picture of Heidelberg Pharma AG logo

HPHA — Heidelberg Pharma AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Wilex posts FY net loss of 6.4 million euros

March 30 (Reuters) - Wilex AG  WL6G.DE : 
    * Financials in line with guidance 
    * Outlook for 2017: increase in sales revenue forecast; 
higher investments in proprietary atac pipeline 
    * Generated sales revenue and other income totaling 2.7 
million euros ($2.90 million) in fiscal year 2016 (previous 
year: 3.9 million euros) 
    * FY net loss for year was 6.4 million euros (previous year: 
6.6 million euros) 
    * Wilex group's FY operating result was -6.4 million euros 
in 2016 fiscal year (previous year: -6.5 million euros) 
    * Expects to generate between 4.0 million euros and 6.0 
million euros in sales revenue and other income (2016: 2.7 
million euros) for 2017 fiscal year 
    * Earnings before interest and taxes (EBIT) for 2017 fiscal 
year are projected to be between -6.0 million euros and -10.0 
million euros (2016: -6.4 million euros) 
 
Source text for Eikon:  ID:nEQ4yxcct  
Further company coverage:  WL6G.DE  
 
($1 = 0.9301 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Heidelberg Pharma AG

See all news